Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA269349
Max Phase: Preclinical
Molecular Formula: C50H74N12O9
Molecular Weight: 987.22
Molecule Type: Small molecule
Associated Items:
ID: ALA269349
Max Phase: Preclinical
Molecular Formula: C50H74N12O9
Molecular Weight: 987.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C1CCCCC1
Standard InChI: InChI=1S/C50H74N12O9/c1-29(2)19-36(42(64)24-43(65)57-38(20-30(3)4)46(67)59-37(45(51)66)21-32-13-8-6-9-14-32)58-47(68)39(22-34-25-52-27-54-34)60-49(70)44(33-15-10-7-11-16-33)61-48(69)41-17-12-18-62(41)50(71)40(56-31(5)63)23-35-26-53-28-55-35/h6,8-9,13-14,25-30,33,36-42,44,64H,7,10-12,15-24H2,1-5H3,(H2,51,66)(H,52,54)(H,53,55)(H,56,63)(H,57,65)(H,58,68)(H,59,67)(H,60,70)(H,61,69)/t36-,37-,38-,39-,40-,41+,42-,44-/m0/s1
Standard InChI Key: FKDAFTKTOYPFII-KMVXVDKCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 987.22 | Molecular Weight (Monoisotopic): 986.5702 | AlogP: 0.99 | #Rotatable Bonds: 26 |
Polar Surface Area: 315.59 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.61 | CX Basic pKa: 6.84 | CX LogP: 0.00 | CX LogD: -0.10 |
Aromatic Rings: 3 | Heavy Atoms: 71 | QED Weighted: 0.05 | Np Likeness Score: -0.01 |
1. Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E.. (1988) Design of rat renin inhibitory peptides., 31 (9): [PMID:3045320] [10.1021/jm00117a003] |
Source(1):